Morbillivirus infections: An introduction

Viruses

Volumn 7, Issue 2, 2015, Pages 699-706

  De Vries, Rory D ^a   Paul Duprex, W ^b   De Swart, Rik L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Distemper; Measles; Morbillivirus; Paramyxovirus; Rinderpest; Vaccination

Indexed keywords

HEMAGGLUTININ;

ARTICLE; CANINE DISTEMPER; CETACEAN MORBILLIVIRUS; CROSS INFECTION; DISEASE SEVERITY; FELINE MORBILLIVIRUS; IMMUNOSUPPRESSIVE TREATMENT; MEASLES; MORBILLIVIRUS; MORBILLIVIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOCINE DISTEMPER; PHYLOGENY; RINDERPEST; VACCINATION; VIRAL CLEARANCE; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS SHEDDING; ANIMAL; CLASSIFICATION; HUMAN; MORBILLIVIRUS INFECTIONS; PHYSIOLOGY; TRANSMISSION;

ANIMALIA; MORBILLIVIRUS; PARAMYXOVIRIDAE; RINDERPEST VIRUS;

ANIMALS; HUMANS; MORBILLIVIRUS; MORBILLIVIRUS INFECTIONS;

EID: 84923038006     PISSN: 19994915     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7020699     Document Type: Article

References (41)

1. Rima, B.K.; Wishaupt, R.G.A.; Welsh, M.J.; Earle, J.A.P. The evolution of morbilliviruses: A comparison of nucleocapsid gene sequences including a porpoise morbillivirus. Vet. Microbiol. 1995, 44, 127–134.
2. Barrett, T. Morbillivirus infections, with special emphasis on morbilliviruses of carnivores. Vet. Microbiol. 1999, 69, 3–13.
3. Woo, P.C.; Lau, S.K.; Wong, B.H.; Fan, R.Y.; Wong, A.Y.; Zhang, A.J.; Wu, Y.; Choi, G.K.; Li, K.S.; Hui, J.; et al. Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial nephritis in domestic cats. Proc. Natl. Acad. Sci. USA 2012, 109, 5435–5440.
4. Drexler, J.F.; Corman, V.M.; Muller, M.A.; Maganga, G.D.; Vallo, P.; Binger, T.; Gloza-Rausch, F.; Rasche, A.; Yordanov, S.; Seebens, A.; et al. Bats host major mammalian paramyxoviruses. Nat. Commun. 2012, 3, 796.
5. Guindon, S.; Gascuel, O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 2003, 52, 696–704.
6. Griffin, D.E. Measles virus. In Fields Virology; Knipe, D.M., Howley, P.M., Eds.; Wolters Kluwer | Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2013; Volume 6, pp. 1042–1069.
7. Durrheim, D.N.; Crowcroft, N.S.; Strebel, P.M. Measles—The epidemiology of elimination. Vaccine 2014, 32, 6880–6883.
8. Strebel, P.M.; Cochi, S.L.; Hoekstra, E.; Rota, P.A.; Featherstone, D.; Bellini, W.J.; Katz, S.L. A world without measles. J. Infect. Dis. 2011, 204 (Suppl. 1), S1–S3.
9. Normile, D. Rinderpest. Driven to extinction. Science 2008, 319, 1606–1609.
10. Normile, D. Rinderpest, deadly for cattle, joins smallpox as a vanquished disease. Science 2010, 330, 435.
11. Roeder, P.L. Rinderpest: The end of cattle plague. Prev. Vet. Med. 2011, 102, 98–106.
12. Baron, M.D.; Parida, S.; Oura, C.A. Peste des petits ruminants: A suitable candidate for eradication? Vet. Rec. 2011, 169, 16–21.
13. Kumar, N.; Maherchandani, S.; Kashyap, S.K.; Singh, S.V.; Sharma, S.; Chaubey, K.K.; Ly, H. Peste des petits ruminants virus infection of small ruminants: A comprehensive review. Viruses 2014, 6, 2287–2327.
14. Beineke, A.; Puff, C.; Seehusen, F.; Baumgartner, W. Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet. Immunol. Immunopathol. 2009, 127, 1–18.
15. Lempp, C.; Spitzbarth, I.; Puff, C.; Cana, A.; Kegler, K.; Techangamsuwan, S.; Baumgartner, W.; Seehusen, F. New aspects of the pathogenesis of canine distemper leukoencephalitis. Viruses 2014, 6, 2571–2601.
16. Jensen, T.; van de Bildt, M.W.G.; Dietz, H.H.; Andersen, T.H.; Hammer, A.S.; Kuiken, T.; Osterhaus, A.D.M.E. Another phocine distemper outbreak in Europe. Science 2002, 297, 209.
17. Grachev, M.A.; Kumarev, V.P.; Mamaev, L.V.; Zorin, V.L.; Baranova, L.V.; Denikjna, N.N.; Belikov, S.I.; Petrov, E.A.; Kolesnik, V.S.; Kolesnik, R.S.; et al. Distemper virus in Baikal seals. Nature 1989, 338, 209–209.
18. Kennedy, S.; Kuiken, T.; Jepson, P.D.; Deaville, R.; Forsyth, M.; Barrett, T.; van de Bildt, M.W.G.; Osterhaus, A.D.M.E.; Eybatov, T.; Duck, C.; et al. Mass die-Off of Caspian seals caused by canine distemper virus. Emerg. Infect. Dis. 2000, 6, 637–639.
19. Bodewes, R.; Morick, D.; van de Bildt, M.W.G.; Osinga, N.; Rubio Garcia, A.; Sanches Contreras, G.J.; Smits, S.L.; Reperant, L.A.P.; Kuiken, T.; Osterhaus, A.D.M.E. Prevalence of phocine distemper virus specific antibodies: Bracing for the next seal epizootic in north-western Europe. Emerg. Microbes Infect. 2013, 2, e3.
20. Duignan, P.J.; van Bressem, M.F.; Baker, J.D.; Barbieri, M.; Colegrove, K.M.; de Guise, S.; de Swart, R.L.; di Guardo, G.; Dobson, A.; Duprex, W.P.; et al. Phocine distemper virus: Current knowledge and future directions. Viruses 2014, 6, 5093–5134.
21. Van Bressem, M.F.; Duignan, P.J.; Banyard, A.; Barbieri, M.; Colegrove, K.M.; de Guise, S.; di Guardo, G.; Dobson, A.; Domingo, M.; Fauquier, D.; et al. Cetacean morbillivirus: Current knowledge and future directions. Viruses 2014, 6, 5145–5181.
22. Tatsuo, H.; Ono, N.; Tanaka, K.; Yanagi, Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000, 406, 893–897.
23. Noyce, R.S.; Bondre, D.G.; Ha, M.N.; Lin, L.T.; Sisson, G.; Tsao, M.S.; Richardson, C.D. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog. 2011, 7, e1002240.
24. Mühlebach, M.D.; Mateo, M.; Sinn, P.L.; Prufer, S.; Uhlig, K.M.; Leonard, V.H.; Navaratnarajah, C.K.; Frenzke, M.; Wong, X.X.; Sawatsky, B.; et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011, 480, 530–533.
25. Delpeut, S.; Noyce, R.S.; Richardson, C.D. The tumor-associated marker, PVRL4 (nectin-4), is the epithelial receptor for morbilliviruses. Viruses 2014, 6, 2268–2286.
26. Visser, I.K.G.; Van Bressem, M.F.; Barrett, T.; Osterhaus, A.D.M.E. Morbillivirus infections in aquatic mammals. Vet. Res. 1993, 24, 169–178.
27. Mateo, M.; Navaratnarajah, C.K.; Syed, S.; Cattaneo, R. The measles virus hemagglutinin beta-propeller head beta4-beta5 hydrophobic groove governs functional interactions with nectin-4 and CD46 but not those with the signaling lymphocytic activation molecule. J. Virol. 2013, 87, 9208–9216.
28. Ludlow, M.; Rennick, L.J.; Nambulli, S.; de Swart, R.L.; Duprex, W.P. Using the ferret model to study morbillivirus entry, spread, transmission and cross-protection. Curr. Opin. Virol. 2014, 4, 15–23.
29. Qiu, W.; Zheng, Y.; Zhang, S.; Fan, Q.; Liu, H.; Zhang, F.; Wang, W.; Liao, G.; Hu, R. Canine distemper outbreak in rhesus monkeys, China. Emerg. Infect. Dis. 2011, 17, 1541–1543.
30. Sakai, K.; Nagata, N.; Ami, Y.; Seki, F.; Suzaki, Y.; Iwata-Yoshikawa, N.; Suzuki, T.; Fukushi, S.; Mizutani, T.; Yoshikawa, T.; et al. Lethal canine distemper virus outbreak in cynomolgus monkeys in Japan in 2008. J. Virol. 2013, 87, 1105–1114.
31. Beauverger, P.; Buckland, R.; Wild, T.F. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: Localization of a common Ld-restricted nucleoprotein epitope. J. Gen. Virol. 1993, 74, 2357–2363.
32. De Vries, R.D.; Ludlow, M.; Verburgh, R.J.; van Amerongen, G.; Yüksel, S.; Nguyen, D.T.; McQuaid, S.; van Binnendijk, R.S.; Osterhaus, A.D.M.E.; Duprex, W.P.; et al. Measles vaccination of non-human primates provides partial protection against infection with canine distemper virus. J. Virol. 2014, 88, 4423–4433.
33. Billeter, M.A.; Naim, H.Y.; Udem, S.A. Reverse genetics of measles virus and resulting multivalent recombinant vaccines: Applications of recombinant measles viruses. Curr. Top. Microbiol. Immunol. 2009, 329, 129–162.
34. Plemper, R.K.; Hammond, A.L. Synergizing vaccinations with therapeutics for measles eradication. Expert Opin. Drug Discov. 2014, 9, 201–214.
35. Krumm, S.A.; Yan, D.; Hovingh, E.S.; Evers, T.J.; Enkirch, T.; Reddy, G.P.; Sun, A.; Saindane, M.T.; Arrendale, R.F.; Painter, G.; et al. An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model. Sci. Transl. Med. 2014, 6, 232ra52.
36. Mathieu, C.; Huey, D.; Jurgens, E.; Welsch, J.C.; de Vito, I.; Talekar, A.; Horvat, B.; Niewiesk, S.; Moscona, A.; Porotto, M. Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides. J. Virol. 2015, 89, 1143–1155.
37. Msaouel, P.; Opyrchal, M.; Domingo Musibay, E.; Galanis, E. Oncolytic measles virus strains as novel anticancer agents. Expert Opin. Biol. Ther. 2013, 13, 483–502.
38. Cattaneo, R.; Miest, T.; Shashkova, E.V.; Barry, M.A. Reprogrammed viruses as cancer therapeutics: Targeted, armed and shielded. Nat. Rev. Microbiol. 2008, 6, 529–540.
39. Takeda, M.; Nakatsu, Y.; Ohno, S.; Seki, F.; Tahara, M.; Hashiguchi, T.; Yanagi, Y. Generation of measles virus with a segmented RNA genome. J. Virol. 2006, 80, 4242–4248.
40. Lapp, S.; Pfankuche, V.M.; Baumgartner, W.; Puff, C. Viral oncolysis—Can insights from measles be transferred to canine distemper virus? Viruses 2014, 6, 2340–2375.
41. De Swart, R.L.; Duprex, W.P.; Osterhaus, A.D.M.E. Rinderpest eradication: Lessons for measles eradication? Curr. Opin. Virol. 2012, 2, 330–334.